.png){kind=logo}
Transitioning from the deep academic waters of a PhD to the fast-paced commercial strategy of a biotech spinout can be a daunting leap. Yet, over the last three months, University of York and Yorkshire Bioscience DTP PhD candidate Greg McNeil has done exactly that.
Joining MetalloBio as part of his BBSRC-funded Professional Internship Placement for PhD Students (PIPS), Greg has officially completed his three-month residency, leaving a lasting impact on the company.
During his residency, Greg was tasked with diving into some of the most complex commercial and regulatory challenges facing the antimicrobial sector today.
Greg took on high-impact projects, including:
Reflecting on his three months with the company, Greg shared:
“The placement with MetalloBio has been a fantastic experience. It has challenged me to think beyond the laboratory and develop a deeper understanding of the commercial, regulatory and strategic considerations that are essential for translating new technologies into successful products.”
Supporting local talent is a core pillar of MetalloBio's identity. As the company grows, it remains dedicated to fostering local talent to prove that world-class science starts with grassroots support.
“Greg has brought a lot to the MetalloBio team in a relatively short space of time. From day one Greg has fit straight into the team and the work he has produced is of the highest quality. It will help strengthen MetalloBio’s non-pharma programme and the development of novel antimicrobial coatings and materials.” says Dr Matthew Culbert, Lead Scientist (Materials) at MetalloBio
Having Greg on board has been an invaluable step in MetalloBio's journey to bridge the gap between groundbreaking research and market-ready solutions.
The entire team wishes Greg the absolute best as he returns to complete his PhD.